This inventor holds 1 USPTO granted patent and 5 published patent applications and 3 EPO patents. Top assignee: Leukocare Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Thomas Kriehuber: Innovator in Biopharmaceutical Drug Production
Introduction
Thomas Kriehuber is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of methods for producing drug products that are both low viscous and highly concentrated. His innovative approach addresses critical challenges in the formulation of biopharmaceuticals.
Latest Patents
Kriehuber holds a patent for a method of producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation. This patent outlines a two-phase process that includes preparing a drug substance of a biomolecule of interest and further processing it to achieve the desired product characteristics. The method involves specific processing steps and the use of a composition containing amino acids and sugars, which enhance the properties of the final drug product.
Career Highlights
Currently, Thomas Kriehuber is associated with Leukocare AG, a company that specializes in biopharmaceutical formulation technologies. His work at Leukocare AG has positioned him as a key player in the biopharmaceutical industry, contributing to advancements that improve drug delivery and efficacy.
Collaborations
Kriehuber collaborates with talented professionals in his field, including Martin Scholz and Kristina Kemter. These collaborations foster innovation and enhance the development of new biopharmaceutical solutions.
Conclusion
Thomas Kriehuber's contributions to biopharmaceutical drug production exemplify the importance of innovation in healthcare. His patented methods and ongoing work at Leukocare AG continue to influence the industry positively.